#7 Clinical Trend: Belsomra
The US Food and Drug Administration (FDA) recently approved Belsomra for the treatment of chronic insomnia. The drug is an orexin receptor antagonist and is the first approved drug of this type.
For more in-depth clinical information, see Suvorexant.
Medscape © 2014 WebMD, LLC
Cite this: Top 10 Trends in Medicine, September 2014 - Medscape - Sep 23, 2014.